🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To describe the effect of routine practice with algluco...
Status
Active Not Recruiting
Location
Advanced Medical Genetics- Site Number : 8400002
Start Date
2021-06-10
Trial ID
NCT04848779
Treatments Being Tested
This Sub-registry is a multicenter, international, longitudinal, observatio...
Status
Recruiting
Location
Barrow Neurol Group- Site Number : 840087
Start Date
2007-06-18
Trial ID
NCT00567073
Glycogen Storage Disease Type II ("GSD-II"; also known as Pompe disease) is...
Status
Completed
Location
University of Florida College of Medicine
Start Date
2003-02
Trial ID
NCT00053573
Treatments Being Tested
The aim of this study is to assess if dosing frequency reduction of algluco...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06575829
Treatments Being Tested
Pompe disease (also known as glycogen storage disease type II) is caused by...
Status
Completed
Location
University of Alabama
Start Date
2005-06
Trial ID
NCT00125879
Treatments Being Tested
Study 701-301 is a single-arm, open-label, switchover study in patients wit...
Status
Terminated
Location
Neuromuscular Research Centre
Start Date
2014-04
Trial ID
NCT01924845
Treatments Being Tested
This is a global, multicenter, prospective, observational registry of patie...
Status
Recruiting
Location
University of Arkansas Medical Science
Start Date
2024-02-16
Trial ID
NCT06121011
Treatments Being Tested
An exploratory, open-labeled study of participants with Pompe disease, who ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-12-14
Trial ID
NCT00701701
Treatments Being Tested
Pompe disease (also known as glycogen storage disease Type II) is caused by...
Status
Completed
Location
Sophia Kinderziekenhuis, Erasmus MC
Start Date
2005-02
Trial ID
NCT00250939
Treatments Being Tested
Primary Objective: To evaluate the safety and tolerability of neoGAA in tr...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2013-08-19
Trial ID
NCT01898364
Treatments Being Tested